Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide

Clinical trial NCT03188419 · COMPLETED

Trial details

NCT number: NCT03188419
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Study type: OBSERVATIONAL

Primary T-cell Immunodeficiency Disorders Common Variable Immunodeficiency

Start date: 2017-06-14
Primary completion: 2019-12-29
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.